Glenmark Speclt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK SPECLT, and when can generic versions of GLENMARK SPECLT drugs launch?
GLENMARK SPECLT has twenty-seven approved drugs.
There are fifteen US patents protecting GLENMARK SPECLT drugs.
There are eighty-two patent family members on GLENMARK SPECLT drugs in thirty-three countries and ninety-two supplementary protection certificates in fifteen countries.
Summary for Glenmark Speclt
| International Patents: | 82 |
| US Patents: | 15 |
| Tradenames: | 23 |
| Ingredients: | 22 |
| NDAs: | 27 |
Drugs and US Patents for Glenmark Speclt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | CALCIPOTRIENE | calcipotriene | CREAM;TOPICAL | 205772-001 | Jun 9, 2015 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glenmark Speclt | CLOBETASOL PROPIONATE | clobetasol propionate | CREAM;TOPICAL | 209095-001 | May 10, 2018 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glenmark Speclt | APREPITANT | aprepitant | CAPSULE;ORAL | 207777-003 | Oct 12, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glenmark Speclt | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 206391-001 | Sep 19, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glenmark Speclt | APREPITANT | aprepitant | CAPSULE;ORAL | 207777-002 | Oct 12, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Glenmark Speclt Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 105792828 | ⤷ Subscribe |
| China | 109475495 | ⤷ Subscribe |
| Canada | 3088490 | ⤷ Subscribe |
| Philippines | 12015502302 | ⤷ Subscribe |
| Canada | 3023355 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Glenmark Speclt Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0734381 | PA2004002,C0734381 | Lithuania | ⤷ Subscribe | PRODUCT NAME: 5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUORMETIL)FENIL)ETOKSI)-3-(4-FLUORFENIL)-4-MORFOLINIL)METIL)-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO/DATE: EU/1/03/262/001, 2003 11 11, EU/1/03/262/002, 2003 11 11, EU/1/03/262/003, 2003 11 11, EU/1/03/262/004, 2003 11 11, EU/1/03/262/005, 2003 11 11, EU/1/03/262/006 20031111 |
| 0734381 | 3/2004 | Austria | ⤷ Subscribe | PRODUCT NAME: APREPITANT, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEMBAREN SALZES; REGISTRATION NO/DATE: EU/1/03/262/001 - EU/1/03/262/006 20031111 |
| 0734381 | SPC/GB04/011 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: APREPITANT, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/03/262/001 20031113; UK EU/1/03/262/002 20031113; UK EU/1/03/262/003 20031113; UK EU/1/03/262/004 20031113; UK EU/1/03/262/005 20031113; UK EU/1/03/262/006 20031113 |
| 0801067 | C00801067/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: SOLIFENACIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57203 12.05.2006 |
| 0734381 | PA2004002 | Lithuania | ⤷ Subscribe | PRODCUT NAME: 5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUORMETIL)FENIL]ETOKSI]-3-(4-FLUORFENIL)-4-MORFOLINIL]METIL]-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO./DATE: EU/1/03/262/001-006/20031111 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
